| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.694 | 0.009 | 0.694 | Antibacterial | 0.631 0.015 DBMET03355 0.636 0.015 DBMET03356 | ||
| 0.409 | 0.016 | 0.421 | Anticoagulant | 0.418 0.015 DBMET03355 0.421 0.015 DBMET03356 | DBMET03356 | |
| 0.349 | 0.004 | 0.349 | Factor Xa inhibitor | 0.171 0.007 DBMET03355 0.208 0.005 DBMET03356 | ||
| 0.35 | 0.029 | 0.35 | Interleukin agonist | 0.207 0.115 DBMET03355 0.197 0.124 DBMET03356 | ||
| 0.23 | 0.025 | 0.359 | Hemostatic | 0.359 0.011 DBMET03355 0.282 0.018 DBMET03356 | DBMET03355 | |
| 0.224 | 0.025 | 0.224 | MAO A inhibitor | |||
| 0.199 | 0.005 | 0.199 | Protein 50S ribosomal subunit inhibitor | 0.127 0.009 DBMET03355 0.122 0.009 DBMET03356 | ||
| 0.172 | 0.003 | 0.172 | Vascular adhesion protein 1 inhibitor | |||
| 0.239 | 0.074 | 0.239 | DNA synthesis inhibitor | 0.17 0.168 DBMET03355 0.199 0.125 DBMET03356 | ||
| 0.198 | 0.065 | 0.198 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.17 | 0.051 | 0.17 | MAO inhibitor | |||
| 0.125 | 0.008 | 0.125 | Factor X inhibitor | 0.067 0.016 DBMET03355 0.087 0.013 DBMET03356 | ||
| 0.125 | 0.012 | 0.125 | DNA gyrase inhibitor | 0.071 0.035 DBMET03355 | ||
| 0.163 | 0.051 | 0.163 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.097 | 0.004 | 0.097 | DNA gyrase subunit A inhibitor | 0.065 0.008 DBMET03355 0.059 0.011 DBMET03356 | ||
| 0.077 | 0.004 | 0.077 | DNA topoisomerase IV inhibitor | 0.039 0.009 DBMET03355 0.035 0.012 DBMET03356 | ||
| 0.115 | 0.052 | 0.115 | Protease inhibitor | 0.099 0.066 DBMET03355 0.111 0.055 DBMET03356 | ||
| 0.184 | 0.122 | 0.294 | Peptidyltransferase inhibitor | 0.228 0.069 DBMET03355 0.294 0.027 DBMET03356 | DBMET03356 | |
| 0.065 | 0.005 | 0.065 | Protein 30S ribosomal subunit inhibitor | 0.042 0.009 DBMET03355 0.04 0.01 DBMET03356 | ||
| 0.104 | 0.048 | 0.104 | Interleukin 12 antagonist | |||
| 0.136 | 0.09 | 0.21 | Insulin secretagoues | 0.21 0.031 DBMET03355 0.159 0.066 DBMET03356 | DBMET03355 | |
| 0.115 | 0.071 | 0.115 | Topoisomerase II inhibitor | |||
| 0.113 | 0.074 | 0.113 | Transcription factor STAT6 inhibitor | |||
| 0.051 | 0.012 | 0.051 | DNA gyrase subunit B inhibitor | 0.04 0.023 DBMET03355 | ||
| 0.051 | 0.013 | 0.051 | Somatostatin 5 antagonist | 0.04 0.018 DBMET03355 0.042 0.017 DBMET03356 | ||
| 0.047 | 0.011 | 0.047 | Melatonin 1 agonist | |||
| 0.085 | 0.052 | 0.085 | Neuropeptide Y antagonist | |||
| 0.041 | 0.015 | 0.041 | Melatonin 2 agonist | |||
| 0.074 | 0.053 | 0.074 | Vanilloid 4 agonist | |||
| 0.045 | 0.025 | 0.045 | DNA-dependent protein kinase inhibitor | |||
| 0.049 | 0.038 | 0.049 | Neuropeptide Y5 antagonist | |||
| 0.194 | 0.183 | 0.194 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.033 | 0.022 | 0.033 | Melatonin agonist | |||
| 0.109 | 0.099 | 0.109 | DNA repair enzyme inhibitor | |||
| 0.134 | 0.125 | 0.332 | Platelet adhesion inhibitor | 0.32 0.028 DBMET03355 0.332 0.024 DBMET03356 | DBMET03356 | |
| 0.035 | 0.028 | 0.035 | ATM kinase inhibitor | |||
| 0.078 | 0.075 | 0.078 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.053 | 0.052 | 0.053 | Glutamate (mGluR) agonist | |||
| 0.094 | 0.111 | 0.151 | Alpha-N-acetylglucosaminidase inhibitor | 0.125 0.073 DBMET03355 0.151 0.054 DBMET03356 | DBMET03356 | |
| 0.083 | 0.104 | 0.098 | Glutamate (mGluR7) agonist | 0.098 0.063 DBMET03355 | DBMET03355 | |
| 0.178 | 0.208 | 0.464 | Antithrombotic | 0.464 0.035 DBMET03355 0.456 0.036 DBMET03356 | DBMET03355 | |
| 0.048 | 0.091 | 0.069 | Neuraminidase (influenza) inhibitor | 0.069 0.036 DBMET03355 | DBMET03355 | |
| 0.022 | 0.065 | 0.046 | GP IIb/IIIa receptor antagonist | 0.046 0.036 DBMET03355 | DBMET03355 | |
| 0.034 | 0.086 | 0.059 | Neuraminidase inhibitor | 0.059 0.044 DBMET03355 | DBMET03355 | |
| 0.124 | 0.18 | 0.388 | Platelet antagonist | 0.388 0.029 DBMET03355 0.249 0.073 DBMET03356 | DBMET03355 | |
| 0.019 | 0.122 | 0.05 | Mannosidase inhibitor | 0.05 0.026 DBMET03356 | DBMET03356 | |
| 0.121 | 0.323 | 0.284 | Antiobesity | 0.284 0.128 DBMET03356 | DBMET03356 | |
| 0.05 | 0.255 | 0.085 | Vanilloid agonist | 0.085 0.058 DBMET03355 | DBMET03355 | |
| 0.13 | 0.358 | 0.221 | Interleukin 2 agonist | 0.204 0.182 DBMET03355 0.221 0.155 DBMET03356 | DBMET03356 | |
| 0.06 | 0.313 | 0.241 | Hypolipemic | 0.241 0.071 DBMET03355 0.218 0.083 DBMET03356 | DBMET03355 | |
| 0.01 | 0.436 | 0.038 | Erythropoietin receptor agonist | 0.038 0.031 DBMET03356 | DBMET03356 | |
| 0.021 | 0.592 | 0.2 | Platelet aggregation inhibitor | 0.2 0.081 DBMET03355 | DBMET03355 | |
| 0.003 | 0.613 | 0.041 | Prostaglandin D2 agonist | 0.041 0.012 DBMET03355 | DBMET03355 | |
| 0.037 | 0.694 | 0.341 | Cyclophilin D inhibitor | 0.256 0.206 DBMET03355 0.341 0.129 DBMET03356 | DBMET03356 | |
| 0.01 | 0.701 | 0.116 | Chelator | 0.116 0.058 DBMET03356 | DBMET03356 | |
| 0.002 | 0.706 | 0.029 | Prostacyclin agonist | 0.029 0.006 DBMET03355 | DBMET03355 | |
| 0.033 | 0.804 | 0.325 | Sodium/bile acid cotransporter inhibitor | 0.325 0.058 DBMET03356 | DBMET03356 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |